KMT2D and lung carcinoma: Lysine (K)-specific methyltransferase 2D (KMT2D) deficiency was reported to impair SEs to form glycolytic vulnerability in lung cancer, promote tumorigenesis in mice and upregulate protumorigenic progression, including glycolysis [9].